Void · Coders disagree
Rules 1.1.0 · as of 14 Sep 2026
Rick Doblin · Said 13 Sep 2020 · doblin-0115
Quote
“our interim analysis suggests that we are in excellent shape for statistical significance, even with 90 participants.”
Summer 2020 column. After agreeing with FDA to end MAPP1 at 90 rather than 100 participants, Doblin expects the trial to still reach statistical significance.